the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma

Clinical trial NCT01717066 · COMPLETED

Trial details

NCT number: NCT01717066
Sponsor: ShenFeng
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Stage I Hepatocellular Carcinoma Stage II Hepatocellular Carcinoma

Start date: 2012-04-01
Primary completion: 2014-12-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.